Highly Promising Antibody Treatment for Yellow Fever Formulated by SMART Researchers with Significant Reduction in Production Timeline
A potential post-infection antibody treatment for yellow fever, named TY014, was devised by a multi-disciplinary research team at SMART. TY014 could complement vaccination efforts and reduce the risk...
